What are the most effective ways of promoting physical exercise in adults?

July 13, 2009

A study published this week in the open access journal PLoS Medicine has found that of six interventions promoting exercise in adults in Australia, encouraging the use of pedometers - simple step counting devices that can be used as a motivational tool - and promoting physical activity through mass media campaigns are the most cost-effective in terms of the money spent for the health benefits they result in. Considered as a package, researchers at the University of Queensland also conclude that these six interventions could reduce death and illness from heart disease, stroke, cancer and diabetes in Australia, with an overall cost saving for the health sector.

Despite its image as a sporting nation, physical inactivity in Australia, in common with many countries in the developed world and an increasing number of developing countries, is a major public health problem. The World Health Organisation recommends at least 30 minutes of moderate physical activity - which could just be brisk walking - five times per week, but at least 60% of Australia's population does not even do this modest amount. In Australia, physical inactivity leads to 10% of all deaths, largely as a result of cardiovascular disease and diabetes, and globally it is thought to cause 1.9 million deaths per year.

Linda Cobiac and colleagues at the University of Queensland reviewed the medical literature to identify a range of interventions to promote physical activity and transport use in adults, which had evidence of effectiveness and which were suitable programs to implement in Australia. They then calculated the cost-effectiveness of six interventions. These included TravelSmart - a program that targeted households in Australia with information about walking paths, bus timetables, and offered incentives to reduce reliance on the car. The six interventions also included two that involved general practitioners (GPs): the standard practice amongst GPs in Australia to screen and prescribe physical activity to inactive patients who visit them, as well as the practice of GPs referring patients to counselling sessions with an exercise physiologist at their local general practice. Internet advice on physical activity, the promotion of pedo meters in the community, and a mass media campaign that promoted physical activity and community events and activities, were also assessed.

A standardized approach has been developed to assess cost-effectiveness of different physical activity programs that are suitable in an Australian context, so the researchers were able to compare these six interventions. They calculated the health outcomes of each intervention in terms of disability adjusted life years (DALYs) - the number of healthy years of life lost as a result of premature death or illness - through already published data on how physical activity causes heart disease, stroke, colon and breast cancer, and diabetes. Offsetting the financial cost of each intervention against the number of years of death or injury (or DALYs) that the intervention averted, they concluded that the program promoting the pedometer as a motivational tool for physical exercise and the mass media campaign were the most cost-effective. The GP practice of referring patients to an exercise physiologist was the least cost-effective, especia lly if time and travel costs were considered.

Only the pedometer program and the mass media campaign of the six interventions resulted in an overall cost-saving, but the researchers stress that if the six interventions are considered together "it is likely that the package of interventions would not only be cost-effective by very likely cost-saving to the health sector." The researchers point out that questions remain about the long-term effectiveness of these programs, and that the quality of the evidence in the literature they reviewed varied. But importantly, the standardized approach to cost-effectiveness offers a model to guide policy-makers in other countries to identify approaches to decrease the burden of disease caused by cardiovascular disease, cancer and diabetes as a result of physical inactivity.
-end-
Note about the embargo for print publications in Australia: In order for journalists working in print in Australia not to be at a disadvantage print publications in Australia may publish stories about this research on the 14th ahead of the 10AM embargo, but we expect all online coverage to observe the embargo.

Funding: This research was funded by an Australian National Health and Medical Research Council Health Services Research grant (no. 351558, http://www.nhmrc.gov.au/grants/types/granttype/strategic/healthserv.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Cobiac LJ, Vos T, Barendregt JJ (2009) Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study. PLoS Med 6(7): e1000110. doi:10.1371/journal.pmed.1000110

Everything published by PLoS Medicine is Open Access: freely available for anyone to read, download, redistribute and otherwise use, as long as the authorship is properly attributed.

For information about PLoS Medicine relevant to journalists, bloggers and press officers, including an outline of our approach to the media, our embargo policy, and how you can re-use of PLoS Medicine material, see the Speaking of Medicine blog: http://speakingofmedicine.plos.org/media/

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000110

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-06-07-cobiac-article.pdf

EDITORS' SUMMARY: http://www.plos.org/press/plme-06-07-cobiac-editors-summary.pdf

CONTACT:
Linda Cobiac
University of Queensland
School of Population Health
Herston Road
Herston, Queensland 4006
Australia
+61 7 3346 4695
l.cobiac@uq.edu.au

TO BE PUBLISHED IN THE PLoS MEDICINE MAGAZINE SECTION:

A 73-Year-Old Man with Long-Term Immobility Presenting with Abdominal Pain

Salomone Di Saverio (Maggiore Hospital Trauma Center, Bologna, Italy) and colleagues discuss the diagnosis and management of a man presenting with symptoms of partial intestinal obstruction.

Funding: The authors received no specific funding for this manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Di Saverio S, Tugnoli G, Orlandi PE, Casali M, Catena F, et al. (2009) A 73-Year-Old Man with Long-Term Immobility Presenting with Abdominal Pain. PLoS Med 6(7): e1000092. doi:10.1371/journal.pmed.1000092

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000107

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-06-07-di-saverio.pdf

CONTACTS:
Salomone Di Saverio
Maggiore Hospital Trauma Center
Department of Surgery, Department of Emergency Medicine
L.go Nigrisoli 2
Bologna, BO 40123
Italy
+ 393207091509
+ 390516478585 (fax)
salo75@inwind.it

About PLoS Medicine

PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org

PLOS

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.